Abstract 10937: Coronary Characteristic in Patients With Impaired Glucose Tolerance
Background: Impaired glucose tolerance (IGT) patients are known to have a higher risk of cardiovascular events and their prognosis is reported to be poor. We, therefore, aimed to compare the complexity and vulnerability of coronary artery disease (CAD) among normal glucose tolerance (NGT), IGT and diabetes mellitus (DM).
Methods: 232 patients (66.4 ± 12.6 years, 201 male) who received percutaneous coronary intervention for coronary artery disease were enrolled in the present study. All of the patients except those already given the diagnosis of DM underwent 75g oral glucose tolerance test (OGTT). The study cohorts were divided into 3 groups; DM (n=118), IGT (n=67), and NGT (n=47). IGT was defined as 2 hour post-load plasma glucose ≥140mg/dl during the OGTT. The lesion complexity was expressed as SYNTAX score. The vulnerability of coronary plaque was determined by optical coherence tomography (OCT).
Results: Glycated hemoglobin (HbA1c) level was significantly higher in DM group (6.7±1.3%) than IGT (5.8±0.3%, P<0.01) or NGT group (5.6±0.3%, P<0.01). The SYNTAX score in IGT group was equivalent to that in DM group (12.7±8.1 vs.11.8±7.8, P = 0.61), and significantly greater than NGT group (10.2±5.8, P<0.05). OCT identified 137 non-target residual plaques in 101 patients. Out of those plaques, 72 plaques contain lipid core (16, 29, and 27 in NGT, IGT and DM groups, respectively). The size of lipid core expressed as mean angles of lipid arc was significantly greater in IGT and DM groups than NGT group (162.0±58.7°, 171.4±59.3° and 130.9±37.7°, respectively, P<0.05). Fibrous cap covering the lipid core in IGT group was equivalent to that in DM group (0.08±0.03mm vs. 0.09±0.03mm, P=0.10), and significantly thinner than NGT group (0.11±0.05mm, P<0.05).
Conclusions: The lesion complexity and plaque vulnerability of IGT patients are not inferior to those of DM patients and significantly greater than NTG patients.
Author Disclosures: K. Suzuki: None. H. Takano: None. A. Tanita: None. H. Sangen: None. Y. Nakamura: None. K. Inui: None. Y. Kubota: None. R. Aoyama: None. S. Nakamura: None. S. Tara: None. K. Murai: None. Y. Tokita: None. K. Asai: None. W. Shimizu: None.
- © 2015 by American Heart Association, Inc.